Picture of OptiNose logo

OPTN — OptiNose News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

OptiNose Inc expected to post a loss of 36 cents a share - Earnings Preview

* OptiNose Inc  OPTN.OQ   OPTN.O  is expected to show a rise in
quarterly revenue when it reports  results on November 3
(estimated). 
* The Yardley, Pennsylvania-based company is expected to report 
a 52.1% increase in revenue to $23.484 million from $15.44
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for OptiNose Inc is for a
loss of 36 cents per share. For the same quarter last year, the
company reported a loss of 43 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for OptiNose Inc is
$12​, about 77.9% above​ its last closing price of $2.65. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 302021   -0.40       -0.41      -0.44     Missed  -6.3
 Mar. 312021   -0.53       -0.53      -0.49     Beat    7.5
 Dec. 312020   -0.46       -0.46      -0.46     Met     0.4​
 Sep. 302020   -0.51       -0.52      -0.43     Beat    17.8
 ​​Jun.        -0.55       -0.56      -0.56     Met     0
 302020                                                 
 Mar. 312020   -0.66       -0.65      -0.63     Beat    3.8​
 Dec. 312019   -0.61       -0.62      -0.58     Beat    6.5
 Sep. 302019   -0.69       -0.69      -0.69     Met     0
 This summary was machine generated November 1 at 18:27 GMT.  All
figures in US dollars unless otherwise stated

Recent news on OptiNose

See all news